Targeting Splenic Myeloid Cells with Nanobiologics to Prevent Postablative Pancreatic Cancer Recurrence via Inducing Antitumor Peripheral Trained Immunity
Abstract Minimally invasive irreversible electroporation ablation shows promise for pancreatic cancer (PCa), but the high recurrence and metastasis rates pose a therapeutic challenge for loco‐regional ablation treatment. Immunotherapy holds promise for preventing tumor recurrence, however, its effic...
Saved in:
| Main Authors: | Shengbo Wu, Weichen Xu, Xuexia Shan, Liping Sun, Shuo Liu, Xixi Sun, Shaoyue Li, Xiaodong Hou, Xiaowan Bo, Chengzhong Peng, Bin Huang, Huixiong Xu, Wenwen Yue |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-06-01
|
| Series: | Advanced Science |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/advs.202413562 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Complications of Percutaneous Irreversible Electroporation for Pancreatic Cancer: A Systematic Review
by: Harsimran Bhatia, et al.
Published: (2025-04-01) -
Electroporation-induced nerve excitability in human brain model under pulsed electric field tumor ablation
by: Fei Guo, et al.
Published: (2025-07-01) -
Pulsed Field Ablation: A Review of Preclinical and Clinical Studies
by: Andrew P. Sullivan, et al.
Published: (2025-03-01) -
Efficacy of irreversible electroporation combined with immunotherapy versus irreversible electroporation alone in locally advanced pancreatic cancer: a propensity score-matched retrospective study
by: Pu Xi, et al.
Published: (2025-07-01) -
Enhancing pancreatic cancer treatment: the role of H101 oncolytic virus in irreversible electroporation
by: Pu Xi, et al.
Published: (2025-03-01)